Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

AASUR in High Risk Prostate Cancer

Phase 2

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Drug: ARN-509
Drug: Abiraterone
Drug: Leuprolide
Radiation: stereotactic, ultra-fractionated radiotherapy

First Posted Date: 2016-05-13

Last Posted Date: 2024-05-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 64

Registration Number: NCT02772588

Locations: 🇺🇸
John Hopkins Medical Center, Baltimore, Maryland, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

and more 8 locations

A Study to See if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE)

Withdrawn

Conditions: Liver Cancer
Liver Metastases

Interventions: Procedure: Hepatic trans-arterial embolization (TAE)
Device: MRI/CT scan
Procedure: biopsy
Other: blood draw

First Posted Date: 2016-05-13

Last Posted Date: 2017-01-31

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT02772575

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection

Not Applicable

Completed

Conditions: C. Difficile Infection
Cancer

Interventions: Biological: Fecal Microbiota Transplantation (FMT)

First Posted Date: 2016-05-12

Last Posted Date: 2024-02-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 10

Registration Number: NCT02770326

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer

Phase 2

Completed

Conditions: Ovarian Cancer

Interventions: Biological: TPIV200
Biological: Durvalumab

First Posted Date: 2016-05-06

Last Posted Date: 2021-11-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 29

Registration Number: NCT02764333

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center at Rockville, Rockville Centre, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

and more 2 locations

A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma

Phase 1

Completed

Conditions: Lymphoma
Mantle Cell Lymphoma
Follicular Lymphoma
Diffuse Large B Cell Lymphoma

Interventions: Drug: Buparlisib
Drug: Ibrutinib

First Posted Date: 2016-04-29

Last Posted Date: 2022-10-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 37

Registration Number: NCT02756247

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States

and more 3 locations

Developing a New Questionnaire About Patient Expectations of Breast Conserving Therapy

Completed

Conditions: Breast Cancer

Interventions: Behavioral: qualitative interviews with patients
Behavioral: questionnaires

First Posted Date: 2016-04-28

Last Posted Date: 2020-04-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 22

Registration Number: NCT02753673

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery

Phase 3

Active, not recruiting

Conditions: Thoracic Surgery
Atrial Fibrillation in High Risk Patients

Interventions: Drug: Amiodarone
Drug: Placebo
Drug: N-Acetylcysteine

First Posted Date: 2016-04-25

Last Posted Date: 2024-05-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 184

Registration Number: NCT02750319

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge, New Jersey, United States
🇺🇸
University of Washington School of Medicine in St. Louis, Saint Louis, Missouri, United States
🇺🇸
Memorial Sloan Kettering Bergen (Consent only), Montvale, New Jersey, United States

and more 6 locations

Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer

Phase 2

Active, not recruiting

Conditions: Early Stage
Breast Cancer
Triple Negative Breast Cancer

Interventions: Drug: Enzalutamide
Behavioral: assessment

First Posted Date: 2016-04-25

Last Posted Date: 2024-06-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 50

Registration Number: NCT02750358

Locations: 🇺🇸
Hartford Healthcare Cancer Institute @ Hartford Hospital, Hartford, Connecticut, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Coney Island Hospital, Brooklyn, New York, United States

and more 9 locations

Anxiety With Cancer in the Elderly (ACE): A Cognitive-behavioral Intervention

Not Applicable

Completed

Conditions: Anxiety
Quality of Life
Depression

Interventions: Behavioral: Managing Anxiety from Cancer (MAC)

First Posted Date: 2016-04-21

Last Posted Date: 2020-10-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 50

Registration Number: NCT02747160

Locations: 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States

Lymphedema Surveillance Study

Recruiting

Conditions: Lymphedema
Breast Cancer

Interventions: Other: Bilateral arm measurements
Other: Body mass index (BMI)
Behavioral: Quality of Life Questionnaire
Other: Blood draw

First Posted Date: 2016-04-19

Last Posted Date: 2024-10-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1250

Registration Number: NCT02743858

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Consent only), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Consent only), Montvale, New Jersey, United States

and more 4 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy